APR 26, 2018 09:11 PM PDT

The Role of the CB1 Receptor on the Relief of Pain

WRITTEN BY: Melissa Moore
3 1 99

The endocannabinoid system is the body’s system that regulates an array of other systems in the body.  It works to maintain homeostasis by the use of receptors, cannabinoids, and metabolic pathways that are responsible for the synthesis and degradation of the cannabinoids and receptors.  When an imbalance is detected, the body will synthesize endocannabinoids to interact with the cannabinoid receptors.  This elicits a chemical response either by inhibiting or stimulating neurotransmitters that work to return the physiological process that is out of balance back to homeostasis.  There are approximately 113 cannabinoids that have been isolated from cannabis, and receptors have been found in mammals, birds, fish, and reptiles.  The receptors are members of the G-protein coupled receptors and are among the most abundant in the brain. 

One of the most infamous receptors of the endocannabinoid system is the CB1 receptor.  This is the receptor that mediates the psychotropic effects of delta-9 tetrahydrocannabinol and possesses a very high binding affinity with this cannabinoid.  The receptor plays a role in a number of therapeutic effects, especially in pain.  The receptor detects a cannabinoid on the outside of the membrane and immediately releases factors on the inside of the nerve terminal.  It affects the efficacy of synaptic transmission and is found on axons and presynaptic and postsynaptic terminals.  These receptors are located throughout the brain, central and peripheral nervous system, connective tissues, gonads, glands, and related organs. They are found in the basal ganglia of the brain and the limbic system.  They are also found in the cerebellum, and in the anterior eye and retina.  However, they are absent in the medulla oblongata which is responsible for respiratory and cardiovascular functions.  The absence of cannabinoid receptors in the medulla oblongata is why there is no mortality risk associated with the use of cannabis. 

A primary role of CB1 receptors is to inhibit neurotransmitter release.  This is assumed from their inhibition of voltage-gated calcium channels and adenylyl cyclase.  This decrease in excitability and neurotransmitter release may underlie some of the psychoactive and anticonvulsant action of cannabinoids.  Studies show inhibition of glutamatergic, GABAergic, glycinergic, cholinergic, noradrenergic and serotonergic neurotransmission in areas of the central nervous system.  Neurotransmission inhibition mediated by the CB1 receptor has also been observed in the peripheral nervous system.  Inhibition of adrenergic, cholinergic, and sensory neuroeffector transmission has also been witnessed in studies.  Along with the activation of potassium channels and MAP kinase.  MAP kinase is involved in directing cellular responses to an array of stimuli.  They regulate crucial cell functions such as proliferation, gene expression, differentiation, mitosis, cell survival and apoptosis. 

The inhibition of neurotransmitters and the activation of potassium channels and MAP kinase is what leads to the sensation of pain relief amongst other things.  Central pain arises from dysfunction of pain signals making their way to the brain.  Cannabis relieves pain by changing the way nerves function.  THC can modulate pain at the level of the spinal cord and brain by directly activating CB1 receptors, and by indirectly increasing opioid receptor activation.  Cannabis can relieve neuropathic pain by weakening the strength of pain signals in the spinal cord and their processing in the brain. 

 

Sources: Molecular Endocrinology, Nature, PubMed, CB1, YouTube

About the Author
  • Currently working with Pharmacannis, a dispensary in Buffalo, NY. Resided in Northern California for the past 15 years working in the cannabis industry as a farmer, breeder, and chemical analyst. Received a bachelor's degree in biology at Keuka College in NY. Studied nursing at Mendocino College in CA, and currently attending University at Buffalo for a Master's of Education in Science and the Public. I have a passion for research with a focus in the field of endocannabinology.
You May Also Like
FEB 06, 2018
Cannabis Sciences
FEB 06, 2018
Medical Cannabis Down Under!
Australia is quickly joining the ranks of countries with pre-boom acceptance and use of cannabis for medical treatment purposes. Australian cultivation of
MAR 08, 2018
Cannabis Sciences
MAR 08, 2018
Cannabis Health and Wellness Fair Announced for April 2018 in Denver Area
Health and wellness trend has piqued the interest of the medical cannabis community in the Denver area and they have come together for a community Cannabis Health and Wellness fair
MAR 23, 2018
Cannabis Sciences
MAR 23, 2018
Congress Protects Medical Marijuana in Spending Bill
A total of 29 U.S. states and D.C. have laws that legalize medical cannabis in some form, and it is allowed recreationally for those aged 21 in nine states and D.C.
APR 26, 2018
Cannabis Sciences
APR 26, 2018
Senators Push to Increase Research Opportunities for Cannabis
Politics are greening up this year in legislation. According to a Pew Research Center survey, 61% of Americans support the legalization of cannabis and an
APR 27, 2018
Cannabis Sciences
APR 27, 2018
Cannabinoid Modulation: How CBD Negates THC
The cannabinoid delta-9 tetrahydrocannabinol (THC) will produce psychoactive effects when consumed.  The outcome is due to the affinity THC has to rec
JUN 13, 2018
Technology
JUN 13, 2018
Hemp Fabric Kills Staph Bacteria
Cloth made from hemp outperforms many other textiles in staph resistance.
Loading Comments...